Axplora

Trending Articles

  1. NHS, MHRA and Medicines UK launch Project Revive to tackle medicine shortages NHS England, the MHRA and Medicines UK have launched Project Revive, a collaborative pilot designed to address critical medicines shortages by fast-tracking dormant...
  2. Isopod Rapid Cleanrooms: the ideal elite controlled environment pod solution for Life Sciences and Engineering start-ups The Guardtech Group’s quick-assembly cleanroom pods combine superior performance, build quality and cost-effectiveness to give new applications the perfect platform to get...
  3. You need to be a subscriber to read this article.
    Click here to find out more.
    Delivering precision: why advanced therapies are redefining pharmaceutical logistics As advanced therapies narrow tolerances and personalise care, pharmaceutical logistics is being redefined as a precision-driven extension of treatment delivery, writes Michael...
  4. Nose-to-brain delivery outperforms systemic BBB technologies according to MetP Pharma The pioneering company has published preclinical data that strongly supports the advantages of its proprietary nose-to-brain drug delivery technology compared with systemic...
  5. AstraZeneca strengthens weight management pipeline with CSPC Pharmaceuticals collaboration The pair have signed a strategic collaboration covering eight obesity and type 2 diabetes programmes, including a clinical-ready GLP-1/GIP asset, AI-driven peptide discovery...

Upcoming event

High Shear = Mixing Success

19 February 2026 | Virtual See all

Related Content

Finance

Axplora announces €100m global investment drive to expand API and ADC manufacturing capacity

Axplora is investing more than €100m across its global network in 2025, with major projects in France, Italy and India aimed at strengthening small molecule API production and expanding antibody-drug conjugate capabilities to support future growth
Manufacturing

Axplora announces €35m expansion at Farmabios to double footprint and fuel long-term growth

This latest investment builds on the €45m already committed during the past 5 years, bringing Axplora’s total recent investment in Farmabios to more than €80 million
Manufacturing

Axplora's Chasse-sur-Rhône CDMO site passes ninth inspection in a row

The API small molecule manufacturing site has been deemed cGMP compliant by the French medicines regulatory authority
You need to be a subscriber to read this article.
Click here to find out more.
Distribution

DCAT preview: the future of pharma manufacturing

Ahead of the upcoming trade show, Dr Kevin Robinson caught up with pharmaceutical industry experts to discuss how they’re innovating for resilience and sustainability in 2025 and beyond
Manufacturing

Axplora expands ADC payload manufacturing capacity at Le Mans site

The CDMO will now be able to produce cytotoxic payload batches of up to 1.5kg, allowing it to better serve its larger clients in the biopharmaceutical space
Manufacturing

Axplora bags a €50m investment to boost GLP-1 manufacturing capabilities at Mourenx, France site

The CDMO has advanced the site's infrastructure, allowing it to provide GLP-1 drug manufacturing services, as well as large-scale API industrial chemistry and chromatography services to its customers
Research & Development

Axplora announces the appointment of its Scientific Advisory Board

This SAB plays a key role in setting market trends and shaping Axplora Research & Development (R&D) activities, while supporting the deployment of innovative technologies and sustainable solutions within the group
Subscribe now